Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon L Croft

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Journal of Medicinal Chemistry|January 9, 2004
Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agentsJunko Ohkanda, Frederick S Buckner, Jeffrey W Lockman, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
New azasterols against Trypanosoma brucei: role of 24-sterol methyltransferase in inhibitor actionLudovic Gros, Victor Manuel Castillo-Acosta, Carmen Jiménez Jiménez, et al.
Molecules (Basel, Switzerland)|December 2, 2017
In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage AntimalarialNicoletta Basilico, Silvia Parapini, Anna Sparatore, et al.
Journal of Medicinal Chemistry|June 28, 2002
Activity of bisphosphonates against Trypanosoma brucei rhodesienseMichael B Martin, John M Sanders, Howard Kendrick, et al.
Journal of Medicinal Chemistry|October 17, 2003
Azasterols as inhibitors of sterol 24-methyltransferase in Leishmania species and Trypanosoma cruziFilippo Magaraci, Carmen Jimenez Jimenez, Carlos Rodrigues, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasisSilvia Orenes Lorente, Juliany C F Rodrigues, Carmen Jiménez Jiménez, et al.
Plos Neglected Tropical Diseases|April 15, 2021
Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drugLisa Sanderson, Marcelo da Silva, Gayathri N Sekhar, et al.
Journal of Medicinal Chemistry|December 30, 2003
Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivoSubhash Ghosh, Julian M W Chan, Christopher R Lea, et al.
The Journal of Pharmacy and Pharmacology|January 31, 2009
Anti-African trypanocidal and antimalarial activity of natural flavonoids, dibenzoylmethanes and synthetic analoguesDjalma A P dos Santos, Patricia A de C Braga, M Fátima das G F da Silva, et al.
Science Translational Medicine|May 3, 2014
Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasisShantanabha Das, Anja Freier, Thouraya Boussoffara, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Journal of Medicinal Chemistry|January 9, 2004
Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agentsJunko Ohkanda, Frederick S Buckner, Jeffrey W Lockman, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
New azasterols against Trypanosoma brucei: role of 24-sterol methyltransferase in inhibitor actionLudovic Gros, Victor Manuel Castillo-Acosta, Carmen Jiménez Jiménez, et al.
Molecules (Basel, Switzerland)|December 2, 2017
In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage AntimalarialNicoletta Basilico, Silvia Parapini, Anna Sparatore, et al.
Journal of Medicinal Chemistry|June 28, 2002
Activity of bisphosphonates against Trypanosoma brucei rhodesienseMichael B Martin, John M Sanders, Howard Kendrick, et al.
Journal of Medicinal Chemistry|October 17, 2003
Azasterols as inhibitors of sterol 24-methyltransferase in Leishmania species and Trypanosoma cruziFilippo Magaraci, Carmen Jimenez Jimenez, Carlos Rodrigues, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasisSilvia Orenes Lorente, Juliany C F Rodrigues, Carmen Jiménez Jiménez, et al.
Plos Neglected Tropical Diseases|April 15, 2021
Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drugLisa Sanderson, Marcelo da Silva, Gayathri N Sekhar, et al.
Journal of Medicinal Chemistry|December 30, 2003
Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivoSubhash Ghosh, Julian M W Chan, Christopher R Lea, et al.
The Journal of Pharmacy and Pharmacology|January 31, 2009
Anti-African trypanocidal and antimalarial activity of natural flavonoids, dibenzoylmethanes and synthetic analoguesDjalma A P dos Santos, Patricia A de C Braga, M Fátima das G F da Silva, et al.
Science Translational Medicine|May 3, 2014
Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasisShantanabha Das, Anja Freier, Thouraya Boussoffara, et al.
Pageof 15